• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We’re Reading: NPs Shifting to Specialty Care; Menopause Medication Insurance Hurdles; New COVID-19 Variants Pose Surge Risk

News
Article

Concerns arise over primary care shortages; women struggle with coverage for effective nonhormonal treatments; FLiRT variants drive concerns amidst waning surveillance and immunity

NPs, PAs Join Specialties as Concerns Rise Over Primary Care Shortages

Increasingly, nurse practitioners (NPs) and physician assistants (PAs) are moving into specialty areas like cardiology and dermatology, broadening their skills and incomes, according to Kaiser Health News. This trend has worried experts who fear primary care might suffer from a shortage of these professionals. Despite the growing presence of NPs in specialty fields, projections suggest there will still be enough clinicians to meet primary care demands, but the distribution might challenge traditional health care models.

New Menopause Medications Face Insurance Hurdles Despite Promising Results

Innovative nonhormonal drugs like Bayer's elinzanetant and Astellas' fezolinetant (Veozah) have shown promise in reducing menopause symptoms, particularly hot flashes, according to NBC News. However, insurance companies often require women to try less effective medications first, making access difficult. Experts and patients have expressed frustration over these insurance barriers, emphasizing the need for better support for menopausal care.

New COVID-19 Variants Pose Summer Surge Risk

COVID-19 levels in the US are at historic lows, but the emergence of new FLiRT variants, particularly KP.2, has raised the possibility of a summer surge, according to CNN. These variants, which are more transmissible and immune-evasive, have overtaken previous strains, complicating predictions. Although the risk remains uncertain, experts urge caution, particularly looking ahead to the fall, when conditions could favor a larger resurgence.

Related Videos
Jennifer Snow, MPA, NAMI
Jennifer Snow, MPA, NAMI
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Adam Brufsky, MD, PhD, University of Pittsburgh
Dr Steven Manobianco
Dr Amrita Basu
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.